833-2263234 (USA Toll-free) +1-224-345-1927 (USA) +86-13250544625(Intl) info@editxor.com
在线客服
[Weekly News]  A Novel type VII CRISPR-Cas system: Discover the Potential of CRISPR Gene Editing

[Weekly News] A Novel type VII CRISPR-Cas system: Discover the Potential of CRISPR Gene Editing

The CRISPR/Cas system represents a revolutionary technology in the field of modern biological sciences, with applications expanding into various areas such as medicine, agriculture, and ecological conservation. Relevant achievements and examples of its applications continue to eme…

[Literature Review] CRISPR/Cas9 Cellular Reporter System to Evaluate Fetal Hemoglobin Induction and T

[Literature Review] CRISPR/Cas9 Cellular Reporter System to Evaluate Fetal Hemoglobin Induction and T

EDITGENE focuses on gene editing, offering highly efficient gene knock-in services using an upgraded CRISPR/Cas9 system, which provides a higher positive rate and broader applicability across gene loci

[Literature Review] SATCAS: A CRISPR/Cas13a-based isothermal one-pot RNA detection platform

[Literature Review] SATCAS: A CRISPR/Cas13a-based isothermal one-pot RNA detection platform

Rapid, cost-effective, and sensitive pathogen nucleic acid detection plays a crucial role in clinical diagnosis and infection management. Traditional CRISPR/Cas13a-based detection methods show great potential in molecular diagnostics; however, most require a transcription step, an…

[Weekly News] CRISPR-Cas9 Screening Shines: A More Sensitive and Specific Method to Identify Fetal He

[Weekly News] CRISPR-Cas9 Screening Shines: A More Sensitive and Specific Method to Identify Fetal He

[Weekly News] CRISPR-Cas9 Screening Shines Again with a More Sensitive and Specific Method to Identify Fetal Hemoglobin Inducers

Prev 1 2 3 4 5 6 7 8 9 10 11 Next